ARCHIVES

Arzerra Promising For Heavily Pre-Treated CLL Patients

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

Cancer Cases To Double By 2050, Annual Report Says

May 31, 2002

In Brief: Satcher Names CDC Director; POG Appoints Monaco To Data Monitoring Committee

September 10, 1993

Review Group Report: NCI Role In Drug Development Seen As Information Provider

November 6, 1998

Organ Systems R01 Grants Doing Okay

February 8, 1985